Myfortic and Pregnancy

The anti-rejection drug Myfortic (mycophenolate sodium) has been given a pregnancy Category D rating by the FDA. This means that it is generally not recommended for use during pregnancy, due to the risk of fetal problems. However, sometimes the benefits will significantly outweigh the risks, and the medication will be prescribed to a woman who is pregnant. Talk to your healthcare provider about your specific situation.

Can Pregnant Women Use Myfortic?

Myfortic® (mycophenolate sodium) is a prescription medication approved to prevent organ rejection after a kidney transplant. Myfortic may be harmful to the fetus if taken during pregnancy.
 

What Is Pregnancy Category D?

The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category D is a classification given to medicines that have been shown to present a risk to the fetus in studies of pregnant women but may still offer benefits that outweigh the risks the drug presents.
 
A pregnancy Category D medicine, such as Myfortic, may still be given to a pregnant woman if the healthcare provider believes that the benefits to the woman outweigh the possible risks to the unborn child.
 
Myfortic increases the risk for miscarriage when used during the first trimester (the first three months of pregnancy). It also increases the risk for birth defects, especially defects of the external ear, face (such as cleft lip and palate), hands, feet, heart, esophagus, and kidneys.
 
Because of the risk associated with its use, Myfortic is generally not recommended for use during pregnancy. However, there may be times when the benefit the medicine presents outweighs the risks, such as if other anti-rejection medicines are not an option. In this case, the risks of not using Myfortic to prevent transplant rejection may outweigh the risks to the fetus from using it.
 
If you are a woman of childbearing potential, your healthcare provider will make sure you are not pregnant by giving you a pregnancy test before starting Myfortic, 8 to 10 days later (after the first test), and at every routine doctor visit after that.
 
You will also receive contraceptive counseling, which is where your healthcare provider talks to you about effective forms of birth control. Women of childbearing potential should use two methods of birth control while on this medication and continuing until six weeks after stopping treatment. Your healthcare provider will advise you about acceptable methods and combinations of methods of birth control.
 
Women who have had tubal ligation, have an intrauterine device (IUD), or whose partners have had a vasectomy do not usually need an additional method of birth control. Women who can commit to abstinence (completely avoiding heterosexual intercourse) may not need birth control. 
 
You should know that Myfortic may make birth control pills less effective (see Myfortic Drug Interactions).
 
Pregnancy and Pain

Myfortic Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.